The consortium academic partners are at the forefront of developments in nanomedicine at the European level.

They are dedicated to offering the highest quality education through well recognized doctoral school and international programmes. The consortium brings experience in terms of management and organization.

  • The University of Nantes (UN) and the University of Angers (UA) and their Doctoral school in Biology and Health (Director Pr. C.Tellier, UN, Co-Director Pr. F. Boury, UA), innovates across all disciplines linked to nanomedicine design (Pr. J.P. Benoit) use of radiopharmaceuticals (Dr. J. Barbet, Director of Aronax) and their application in therapy (Pr. O. Couturier and Pr. P. Menei) and tissue engineering (Pr. P. Weiss) (in tight collaboration with hospitals where clinical trials on nanomedical devices have been conducted).

Click here to read the University of Angers presentation

Click here to read the University of Nantes presentation

  •  The Université catholique de Louvain (UCL) and the University of Liège (ULg) excel in Doctoral training through Thematic Doctoral School in pharmaceutical sciences (Director Pr. V. Préat) and material chemistry of National Fund of Scientific research. Belgium groups experience in research is complementary through drug delivery systems (Pr. V. Préat), polymer chemistry (Pr. C. Jérome), Cancer research (Pr. O.Feron) and medical imaging (Pr. A. Luxen, Pr. B.Gallez) or nuclear medicine (Pr. R. Huxtin).

Click here to see the Université catholique de Louvain presentation

Click here to see the University of Liège presentation

  •  The University of Nottingham (UNott) has a Doctoral Training Centre in Targeted Therapeutics with strong expertise in polymer conjugates based therapies (Pr. A. Cameron) and a world-leading role in tissue engineering and regenerative medicine (Pr. K.M. Shakesheff).

Click here to see the University of Nottingham presentation

  •  The University of Santiago de Compostela (USC) (International Excellency Campus Vida) has a leading pole in nanotechnologies applied to the design of Drug Delivery Systems (Pr.. M.J Alonso) with strong existing technology transfers towards the clinic (Pr.. R. Lopez) and industry.

Click here to see the University of Santiago de Compostela presentation

The NanoFar consortium forms the largest research community in nanomedicine in Europe. The research laboratories bring together more than 300 researchers in the concerned field.

NanoFar offers a training environment that will inspire students to tackle difficulties associated with the multiple levels of nanomedicine using new and multidisciplinary techniques with a clear translational perspective on bedside-to-bench and bench-to-bedside activities.
This is possible thanks to its associated partners.

Click here to acceed the presentation of NanoFar associated partners